- Home
- PROK vs JOF Comparison
PROK vs JOF Comparison
Compare PROK & JOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROK | JOF |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.4M | 351.6M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PROK | JOF |
|---|---|---|
| Price | $1.68 | $12.41 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 57.7K |
| Earning Date | 11-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $893,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.83 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1075.00 | N/A |
| 52 Week Low | $1.30 | $10.06 |
| 52 Week High | $3.48 | $12.85 |
Technical Indicators
Market Signals| Indicator | PROK | JOF |
|---|---|---|
| Relative Strength Index (RSI) | 49.14 | 47.74 |
| Support Level | $1.55 | $12.15 |
| Resistance Level | $1.76 | $12.76 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 48.39 | 23.19 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.